Urological cancer, Malmö
271 – 280 of 554
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
The Proteome of Primary Prostate Cancer.
- Contribution to journal › Article
-
Mark
Whole-Body and Microenvironmental Localization of Radium-223 in Naïve and Mouse Models of Prostate Cancer Metastasis.
- Contribution to journal › Article
-
Mark
Prediction of clinical progression after radical prostatectomy in a nationwide population-based cohort
- Contribution to journal › Article
-
Mark
Making Predictive Biomarkers Readily Available
- Contribution to journal › Debate/Note/Editorial
-
Mark
Value of treatment in clinical trials versus the real world : the case of abiraterone acetate (Zytiga) for postchemotherapy metastatic castration-resistant prostate cancer patients in Sweden
- Contribution to journal › Article
-
Mark
Preparedness for side effects and bother in symptomatic men after radical prostatectomy in a prospective, non-randomized trial, LAPPRO
- Contribution to journal › Article
-
Mark
Accurate prediction tools in prostate cancer require consistent assessment of included variables
- Contribution to journal › Article
-
Mark
Bone Scan Index as an Imaging Biomarker in Metastatic Castration-resistant Prostate Cancer : A Multicentre Study Based on Patients Treated with Abiraterone Acetate (Zytiga) in Clinical Practice
- Contribution to journal › Article
-
Mark
Bone Scan Index and Progression-free Survival Data for Progressive Metastatic Castration-resistant Prostate Cancer Patients Who Received ODM-201 in the ARADES Multicentre Study
- Contribution to journal › Article
-
Mark
Grey Zones in the Field of Urinary Tract Infections
- Contribution to journal › Debate/Note/Editorial
